News Headlines Article

Most Neurogenic Fibrosis Cases Associated with Three MRI Gadolinium Agents
Health Leaders Media

Radiologists should avoid using three types of common gadolinium based contrast agents when administering MRIs to patients with chronic or acute kidney disease, according to an advisory from the American College of Radiology. That’s because these three types—gadodiamide or Omniscan by GE Healthcare, gadopentetate dimeglumine or Magnevist by Bayer Healthcare Pharmaceuticals, and Gadoversetamide by OptiMARK by Covidien—are linked with a greater number of nephrogenic systemic fibrosis cases, and make up Group I, according to the ACR.